Key points are not available for this paper at this time.
Abstract
Tumor growth response to eribulin and copanlisib, either alone or in combination, in additional TNBC PDX models
问 AI
Like
Bookmark
Share
View Full Paper
问 AI
Like
Bookmark
Share
View Full Paper
Supplementary Figure S3 from Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models | Synapse